Receives CE Mark Approval from European Notified Body EVO Viva Implantable Collamer® Lens Corrects Near, Intermediate and Distance Vision LAKE FOREST, Calif. --(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that EVO Viva ™, STAAR`s innovative presbyopia correcting implantable Collamer® lens (`ICL`), has been approved for sale. STAAR received CE Mark approval of the presbyopic indication for its EVO+ Visian® ICL with Aspheric (EDOF) Optic, commercially marketed as `EVO Viva `, from its European Notified Body, DEKRA, on July 2, 2020 . EVO Viva will...
|
